United States · FDA National Drug Code directory
Erythromycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55289-075_4199686c-7009-b215-e063-6294a90aaa02
- Product NDC
- 55289-075
- Form
- TABLET, FILM COATED
- Composition / generic term
- Erythromycin
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110906
- Source listing expiry
- 20261231
Source-listed ingredients
- ERYTHROMYCIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-03) · 55289-075-03
- 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-40) · 55289-075-40
- 56 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-075-56) · 55289-075-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →